Scinai Immunotherapeutics Ltd.
- Last sale
- Nov 12, 2026 · -9.80%
- Market cap
- $1.60M
- 3.47M shares
- Filings
- 499
FY 2025+99.2% FY25 yoy
FY 2025N/M FY25 yoy
FY 2025N/M FY25 yoy
FY 2025derivedN/M FY25 yoy
Q2 2025−60.0% FY23 yoy
FY 2025−15.4% FY25 yoy
- $1.60M
- —
- 1.2×
- 0.2×
- -379.45%
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $1,311,000 | reported | |
| FY 2024 | 2024-12-31 | $658,000 | reported |
Biological products, except diagnostic substances
Scinai Immunotherapeutics Ltd. is the 77th largest of the 176 covered companies the SEC files under this code, by revenue. SIC 2836
CompanyRevenueGrowthNet marginMarket cap
ALGSAligos Therapeutics, Inc.$2.2M39.5%1,106.7%$12.6MHUMAHumacyte, Inc.$2.0M—2,003.6%$165.5MOTLKOutlook Therapeutics, Inc.$1.4M—4,416.2%$107.1M
SCNIScinai Immunotherapeutics Ltd. (this company)$1.3M99.2%633.6%$1.6M
INBXInhibrx Biosciences, Inc.$1.3M550.0%10,773.5%$1.3BPLURPluri Inc.$1.0M24.0%2,344.6%$17.3MPROKProkidney Corp.$893.0K1,075.0%7,725.2%$347.7MIMAImageneBio, Inc.$800.0K77.1%5,668.6%$45.0MCRDFCardiff Oncology, Inc.$593.0K13.2%7,732.0%$56.8MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Scinai Immunotherapeutics Ltd. · CIK 1611747 · Engraved from SEC EDGAR